I don't think the funding agreement will ever be used. It only serves as a contingency in the event that the lupus trial does not yield a partner and allows the respiratory franchise to continue.
Ann: Change of Director's Interest Notice - M Glass, page-9
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IVX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.001(50.0%) |
Mkt cap ! $20.29M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.2¢ | $98.33K | 33.36M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1971861 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 7665218 | 11 |
View Market Depth
| Last trade - 16.10pm 18/09/2024 (20 minute delay) ? |
| IVX (ASX) Chart |